Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Fibrocell to Present at Upcoming Industry and Investor Conferences
-
Audentes Therapeutics to Participate in Upcoming Investor Conferences
-
Fibrocell to Present at Upcoming Industry and Investor Conferences
-
Ocugen to Present at Two Upcoming Investor Conferences
-
PTC Therapeutics to Participate at Upcoming Investor Conference
-
Arrowhead Pharmaceuticals to Present at Upcoming October 2018 Conferences
-
Rocket Pharmaceuticals Announces Participation at Upcoming Conferences
-
Arcturus Therapeutics to Present at October Investor Conferences
-
Sangamo Therapeutics Announces Participation At Upcoming Investor and Industry Conferences
-
Intellia Therapeutics to Present at October Healthcare Investor Conferences
-
Kodiak Sciences Inc. Announces Launch of Initial Public Offering
-
UPDATE: Chardan Upgrades KVH Industries (KVHI) to Buy
-
Megalith Financial Acquisition Corp. Announces Closing of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
-
Megalith Financial Acquisition Corp. Announces Closing of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
-
Exicure, Inc. (XCUR) Reports Positive Phase 1 Results for Lead Immuno-Oncology Asset
-
Axovant to Present at Two Upcoming Investor Conferences
-
Exicure Announces Positive Phase 1 Results for its Lead Immuno-Oncology Asset
-
BioSig Technologies (BSGM) PT Raised to $12.50 at Chardan Ahead of NASDAQ Uplisting
-
Chardan Advises NovellusDX in Cross-Border Biotech Merger
-
Cancer Genetics (CGIX) and NovellusDx Enter Definitive Agreement to Merge
-
Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge
-
VBL Therapeutics to Present at Upcoming Conferences in October
-
Chardan Capital Markets Starts HMS Holdings (HMSY) at Neutral
-
ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Chardan Capital Markets Downgrades Applied Genetic Technologies Corp. (AGTC) to Neutral
-
EdtechX Holdings Acquisition Corp. Announces Filing of Registration Statement
-
Kodiak Sciences Files Registration Statement for Proposed Initial Public Offering
-
ProQR (PRQR) Prices 5.75M Share Common Offering at $15.75/Sh
-
ProQR Prices $90.6 Million Underwritten Public Offering of Ordinary Shares
-
Arrowhead Research (ARWR) PT Raised to $24.50 at Chardan Capital Markets
-
Chardan Capital Markets Reiterates Buy on 22nd Century Group (XXII) Following Study
-
Chardan Capital Markets Starts iRhythm Technologies (IRTC) at Buy
-
ProQR Therapeutics N.V. (PRQR) PT Raised to $21 at Chardan Capital Markets
-
HealthEquity, Inc (HQY) PT Raised to $118 at Chardan Capital Markets
-
Jerrick Media Holdings, Inc. Accomplished Converting Over $12,000,000 of Securities In Addition to Placing $3,000,000 of Common Stock and Warrants as Part of an Upround Private Placement
-
UPDATE: Chardan Capital Markets Starts R1 RCM Inc (RCM) at Buy
-
Chardan Capital Markets Starts Tocagen Inc. (TOCA) at Buy
-
Megalith Financial Acquisition Corp. Announces Closing of $150,000,000 Initial Public Offering
-
Megalith Financial Acquisition Corp. Announces Closing of $150,000,000 Initial Public Offering
-
Chardan Serves as Sole Book-Runner for Megalith Financial Acquisition Corp.
-
Megalith Financial Acquisition Corp. (MFAC) Prices 15M Unit IPO at $10/Unit
-
Megalith Financial Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
-
Megalith Financial Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
-
Chardan Capital Markets Starts MeiraGTx Holdings plc (MGTX) at Buy
-
Atlantic Acquisition Corp. Announces Completion of Merger with HF Group Holding Corp.
-
Genius Brands International Raises $4.5 Million in Funding Round Led by Robert Wolf's 32 Ventures
-
Safe-T Announces Closing of $7.335 Million Underwritten Public Offering
-
Chardan Capital Markets acts as Sole Placement Agent in $10 Million Securities Purchase
-
Safe-T Group Ltd. (SFET) IPO Opens 16% Lower
-
Pre-Open Movers 08/17: (IZEA) (ZOES) (JWN) Higher; (ZN) (VNET) (DF) Lower (more...)

